(Total Views: 425)
Posted On: 08/12/2020 9:11:12 AM
Post# of 149219
“Clearly the p value in severe is going to be excellent.”
100% agree. The results from the small M2M trial indicate that the interim analysis of the severe trial will show a clear benefit in the leronlimab group. I hope that the severe trial is near 195 patients and we should get an update on the CC today.
100% agree. The results from the small M2M trial indicate that the interim analysis of the severe trial will show a clear benefit in the leronlimab group. I hope that the severe trial is near 195 patients and we should get an update on the CC today.
(1)
(0)Scroll down for more posts ▼
